Literature DB >> 18340075

Prescribing for older people.

James C Milton1, Ian Hill-Smith, Stephen H D Jackson.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18340075      PMCID： PMC2267940          DOI： 10.1136/bmj.39503.424653.80

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  26 in total

1.  A randomised controlled trial of the effect of educational outreach by community pharmacists on prescribing in UK general practice.

Authors:  Nick Freemantle; Irwin Nazareth; Martin Eccles; John Wood; Andrew Haines
Journal:  Br J Gen Pract       Date:  2002-04       Impact factor: 5.386

2.  Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts.

Authors:  Donna M Fick; James W Cooper; William E Wade; Jennifer L Waller; J Ross Maclean; Mark H Beers
Journal:  Arch Intern Med       Date:  2003 Dec 8-22

Review 3.  Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications.

Authors:  A A Mangoni; S H D Jackson
Journal:  Br J Clin Pharmacol       Date:  2004-01       Impact factor: 4.335

Review 4.  The implications of a growing evidence base for drug use in elderly patients. Part 1. Statins for primary and secondary cardiovascular prevention.

Authors:  A A Mangoni; S H D Jackson
Journal:  Br J Clin Pharmacol       Date:  2006-05       Impact factor: 4.335

5.  Prescribing in old age.

Authors:  C G Swift
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-26

6.  Potentially inappropriate prescribing for geriatric inpatients: an acute care of the elderly unit compared to a general medicine service.

Authors:  Rebecca F Edwards; Tina M Harrison; Steven M Davis
Journal:  Consult Pharm       Date:  2003-01

Review 7.  Systematic review of whether nurse practitioners working in primary care can provide equivalent care to doctors.

Authors:  Sue Horrocks; Elizabeth Anderson; Chris Salisbury
Journal:  BMJ       Date:  2002-04-06

8.  Using prescribing indicators to measure the quality of prescribing to elderly medical in-patients.

Authors:  Gwenno M Batty; Robert L Grant; Reena Aggarwal; Derek Lowe; Jonathon M Potter; Michael G Pearson; Stephen H D Jackson
Journal:  Age Ageing       Date:  2003-05       Impact factor: 10.668

Review 9.  The challenge of managing drug interactions in elderly people.

Authors:  Louise Mallet; Anne Spinewine; Allen Huang
Journal:  Lancet       Date:  2007-07-14       Impact factor: 79.321

10.  Is the number of prescribing physicians an independent risk factor for adverse drug events in an elderly outpatient population?

Authors:  Jacqueline L Green; Jonathan N Hawley; Kimberly J Rask
Journal:  Am J Geriatr Pharmacother       Date:  2007-03
View more
  73 in total

1.  Improving the pharmacologic management of pain in older adults: identifying the research gaps and methods to address them.

Authors:  M Cary Reid; David A Bennett; Wen G Chen; Basil A Eldadah; John T Farrar; Bruce Ferrell; Rollin M Gallagher; Joseph T Hanlon; Keela Herr; Susan D Horn; Charles E Inturrisi; Salma Lemtouni; Yu Woody Lin; Kaleb Michaud; R Sean Morrison; Tuhina Neogi; Linda L Porter; Daniel H Solomon; Michael Von Korff; Karen Weiss; James Witter; Kevin L Zacharoff
Journal:  Pain Med       Date:  2011-08-11       Impact factor: 3.750

Review 2.  Evidence for compliance with long-term medication: a systematic review of randomised controlled trials.

Authors:  Michelle A King; Rebecca L Pryce
Journal:  Int J Clin Pharm       Date:  2013-11-30

3.  Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study.

Authors:  Alessandro Nobili; Giuseppe Licata; Francesco Salerno; Luca Pasina; Mauro Tettamanti; Carlotta Franchi; Luigi De Vittorio; Alessandra Marengoni; Salvatore Corrao; Alfonso Iorio; Maura Marcucci; Pier Mannuccio Mannucci
Journal:  Eur J Clin Pharmacol       Date:  2011-01-11       Impact factor: 2.953

4.  Co-morbidity and potential treatment conflicts in elderly heart failure patients: a retrospective, cross-sectional study of administrative claims data.

Authors:  Gillian E Caughey; Elizabeth E Roughead; Sepehr Shakib; Agnes I Vitry; Andrew L Gilbert
Journal:  Drugs Aging       Date:  2011-07-01       Impact factor: 3.923

5.  Prescription of addictive and non-addictive drugs to home-dwelling elderly.

Authors:  Inger Cathrine Kann; Christofer Lundqvist; Hilde Lurås
Journal:  Drugs Aging       Date:  2014-06       Impact factor: 3.923

6.  Medication non-adherence among elderly patients newly discharged and receiving polypharmacy.

Authors:  L Pasina; A L Brucato; C Falcone; E Cucchi; A Bresciani; M Sottocorno; G C Taddei; M Casati; C Franchi; C D Djade; A Nobili
Journal:  Drugs Aging       Date:  2014-04       Impact factor: 3.923

7.  A comparison of the application of STOPP/START to patients' drug lists with and without clinical information.

Authors:  Cristín Ryan; Denis O'Mahony; Dónal Óg O'Donovan; Emer O'Grady; Peter Weedle; Julia Kennedy; Stephen Byrne
Journal:  Int J Clin Pharm       Date:  2012-12-09

8.  Geographical differences in the prevalence of chronic polypharmacy in older people: eleven years of the EPIFARM-Elderly Project.

Authors:  Carlotta Franchi; Massimo Cartabia; Paolo Risso; Daniela Mari; Mauro Tettamanti; Alberto Parabiaghi; Luca Pasina; Codjo Djignefa Djade; Ida Fortino; Angela Bortolotti; Luca Merlino; Alessandro Nobili
Journal:  Eur J Clin Pharmacol       Date:  2013-03-28       Impact factor: 2.953

9.  Qualitative insights into general practitioners views on polypharmacy.

Authors:  Sibyl Anthierens; Anneleen Tansens; Mirko Petrovic; Thierry Christiaens
Journal:  BMC Fam Pract       Date:  2010-09-15       Impact factor: 2.497

10.  Potential prescription patterns and errors in elderly adult patients attending public primary health care centers in Mexico City.

Authors:  José Antonio Corona-Rojo; Marina Altagracia-Martínez; Jaime Kravzov-Jinich; Laura Vázquez-Cervantes; Edilberto Pérez-Montoya; Consuelo Rubio-Poo
Journal:  Clin Interv Aging       Date:  2009-09-01       Impact factor: 4.458
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.